Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Pfister

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2014
Pneumocystis jirovecii pneumonia in everolimus-treated renal cell carcinomaMarie-Charlotte Loron, Steven Grange, Dominique Guerrot, et al.
Urology|July 26, 2011
Radical prostatectomy for high-risk prostate cancer defined by preoperative criteria: oncologic follow-up in national multicenter study in 813 patients and assessment of easy-to-use prognostic substratificationGuillaume Ploussard, Alexandra Masson-Lecomte, Jean-Baptiste Beauval, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2012
The neuropeptide 26RFa is expressed in human prostate cancer and stimulates the neuroendocrine differentiation and the migration of androgeno-independent prostate cancer cellsJessy Alonzeau, David Alexandre, Lydie Jeandel, et al.
Journal of Surgical Oncology|November 19, 2016
Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter studyMarie Dusaud, Bernard Malavaud, Younes Bayoud, et al.
Urologic Oncology|November 20, 2020
Comparison of the prognosis of primary vs. progressive muscle invasive bladder cancer after radical cystectomy: Results from a large multicenter studyFrançois-Xavier Nouhaud, Marouene Chakroun, Claire Lenormand, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 12, 2015
Morbidity-mortality conference for adverse events associated with totally implanted venous access for cancer chemotherapyVéronique Merle, Hélène Marini, Frédéric Di Fiore, et al.
BJU International|December 17, 2008
Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinomaLaurent Zini, Jean-Jacques Patard, Umberto Capitanio, et al.
The Journal of Urology|December 4, 2012
Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology reviewMorgan Rouprêt, Thomas Seisen, Eva Compérat, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 23, 2005
[Urothelial tumors]Jacques Irani, Stéphane Bernardini, Jean-Louis Bonnal, et al.
Neurorehabilitation and Neural Repair|June 6, 2018
First-in-Man Intrathecal Application of Neurite Growth-Promoting Anti-Nogo-A Antibodies in Acute Spinal Cord InjuryKlaus Kucher, Donald Johns, Doris Maier, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2014
Pneumocystis jirovecii pneumonia in everolimus-treated renal cell carcinomaMarie-Charlotte Loron, Steven Grange, Dominique Guerrot, et al.
Urology|July 26, 2011
Radical prostatectomy for high-risk prostate cancer defined by preoperative criteria: oncologic follow-up in national multicenter study in 813 patients and assessment of easy-to-use prognostic substratificationGuillaume Ploussard, Alexandra Masson-Lecomte, Jean-Baptiste Beauval, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2012
The neuropeptide 26RFa is expressed in human prostate cancer and stimulates the neuroendocrine differentiation and the migration of androgeno-independent prostate cancer cellsJessy Alonzeau, David Alexandre, Lydie Jeandel, et al.
Journal of Surgical Oncology|November 19, 2016
Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter studyMarie Dusaud, Bernard Malavaud, Younes Bayoud, et al.
Urologic Oncology|November 20, 2020
Comparison of the prognosis of primary vs. progressive muscle invasive bladder cancer after radical cystectomy: Results from a large multicenter studyFrançois-Xavier Nouhaud, Marouene Chakroun, Claire Lenormand, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 12, 2015
Morbidity-mortality conference for adverse events associated with totally implanted venous access for cancer chemotherapyVéronique Merle, Hélène Marini, Frédéric Di Fiore, et al.
BJU International|December 17, 2008
Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinomaLaurent Zini, Jean-Jacques Patard, Umberto Capitanio, et al.
The Journal of Urology|December 4, 2012
Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology reviewMorgan Rouprêt, Thomas Seisen, Eva Compérat, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 23, 2005
[Urothelial tumors]Jacques Irani, Stéphane Bernardini, Jean-Louis Bonnal, et al.
Neurorehabilitation and Neural Repair|June 6, 2018
First-in-Man Intrathecal Application of Neurite Growth-Promoting Anti-Nogo-A Antibodies in Acute Spinal Cord InjuryKlaus Kucher, Donald Johns, Doris Maier, et al.
Pageof 13